Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Market Cap | Dividend Yield | Payout Ratio | Last Dividend | Annual Dividend | Dividend Percentile | Dividend Dropped Count (L10Y) | Ex-dividend Date | Div. Payment Date |
|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $34.45B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CORT | CORCEPT THERAPEUTICS INC | $4.02B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NVO | NOVO NORDISK A S | $232.79B | 2.10% | 30.60% | $1.0992 | $1.10 | 46% | 9 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $52.87B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $3.18B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $469.52M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCEL | VERICEL CORP | $1.80B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ARGX | ARGENX SE | $51.27B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| KRYS | KRYSTAL BIOTECH INC | $7.16B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| GMAB | GENMAB A | $20.43B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| TECH | BIO-TECHNE CORP | $9.29B | 0.54% | 64.00% | $0.0800 | $0.32 | 11% | 1 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $3.74B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ADMA | ADMA BIOLOGICS INC | $4.26B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ABEO | ABEONA THERAPEUTICS INC | $287.76M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MNKD | MANNKIND CORP | $1.72B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VCYT | VERACYTE INC | $3.35B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| RPRX | ROYALTY PHARMA PLC | $22.43B | 2.26% | 49.40% | $0.2200 | $0.88 | 50% | 0 | ||
| CRMD | CORMEDIX INC | $958.07M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| NAGE | NIAGEN BIOSCIENCE INC | $498.79M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| EXEL | EXELIXIS INC | $11.68B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $114.71B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HALO | HALOZYME THERAPEUTICS INC | $8.27B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $139.93M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $11.42B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| APLS | APELLIS PHARMACEUTICALS INC | $3.27B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $2.02B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.15B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $2.85B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| MDXG | MIMEDX GROUP INC | $959.70M | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INVA | INNOVIVA INC | $1.49B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| REGN | REGENERON PHARMACEUTICALS INC | $81.59B | 0.45% | 6.10% | $0.8800 | $3.52 | 8% | 0 | ||
| UTHR | UNITED THERAPEUTICS CORP | $21.39B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $4.45B | N/A | 0.00% | N/A | N/A | N/A | N/A | ||
| INCY | INCYTE CORP | $19.91B | N/A | 0.00% | N/A | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.